There are 134 resources available
49MO - Updated progression-free survival (PFS) in patients (pts) with newly diagnosed advanced ovarian cancer (OC) treated with rucaparib (RUC) in ATHENA-MONO
Presenter: Rebecca Kristeleit
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
41MO - ESR1 mutation in untreated endometrial cancer: Prevalence, characteristics and prognostic implications from the UTOLA trial
Presenter: Felix Blanc-Durand
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
42MO - Interpreting somatic POLE mutations in endometrial cancer emerging from comprehensive genomic profiling
Presenter: Rita Trozzi
Session: Mini Oral session 2
Resources:
Abstract
24MO - TROP-2, TF and NECTIN4 as targets for ADC treatment in cervical cancer
Presenter: Mari Halle
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
Invited Discussant abstracts 49MO, 41MO, 42MO and 24MO
Presenter: Ioana Braicu
Session: Mini Oral session 2
Resources:
Slides
Webcast
Q&A
Session: Mini Oral session 2
Resources:
Webcast
Is concomitant chemoradiation still the standard of care for locally advanced cervical cancer?
Presenter: Domenica Lorusso
Session: Cervical cancer: Flying across the borders
Resources:
Slides
Webcast
The immunotherapy revolution in advanced cervical cancer
Presenter: Bradley Monk
Session: Cervical cancer: Flying across the borders
Resources:
Slides
Webcast
What's next?
Presenter: Toon Van Gorp
Session: Cervical cancer: Flying across the borders
Resources:
Slides
Webcast
Q&A and discussion
Session: Cervical cancer: Flying across the borders
Resources:
Webcast